RPL13P12 and glioblastoma: In a study by Yekula et al., RPL13P12 was enriched in serum-derived extracellular vesicle RNA from glioblastoma patients responding to dacomitinib [27], partially strengthening the argument that INDIE genes may be more easily included in biomarkers.